Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Line... Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures. Mehr anzeigen
$30 Million Upfront With Up to an Additional $36 Million of Aggregate Gross Proceeds Upon the Exercise in Full of Clinical Milestone-linked Common Warrants Lineage Cell Therapeutics, Inc. (NYSE...
$30 Million Upfront With Up to an Additional $36 Million of Aggregate Gross Proceeds Upon the Exercise in Full of Clinical Milestone-linked Common Warrants Lineage Cell Therapeutics, Inc. (NYSE...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.022 | 4.15094339623 | 0.53 | 0.5682 | 0.481 | 2140285 | 0.50199327 | CS |
| 4 | -0.068 | -10.9677419355 | 0.62 | 0.6201 | 0.481 | 3892713 | 0.547074 | CS |
| 12 | -0.3426 | -38.2964453387 | 0.8946 | 0.97 | 0.481 | 1767574 | 0.61187698 | CS |
| 26 | -0.328 | -37.2727272727 | 0.88 | 1.15 | 0.481 | 1095680 | 0.69402716 | CS |
| 52 | -0.428 | -43.6734693878 | 0.98 | 1.61 | 0.481 | 1015023 | 0.89942273 | CS |
| 156 | -1.848 | -77 | 2.4 | 2.71 | 0.481 | 721203 | 1.19195659 | CS |
| 260 | -0.038 | -6.4406779661 | 0.59 | 3.1316 | 0.481 | 885412 | 1.52110886 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SPYSPDR S&P 500 | US$ 591,15 (0,86%) | 121,43M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,1628 (-3,25%) | 114,37M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,30 (3,80%) | 107,24M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,435 (7,27%) | 93,88M |
| KULRKULR Technology Group Inc | US$ 2,885 (28,79%) | 75,32M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
